Trademark Overview
On Tuesday, November 25, 2025, a trademark application was filed for T-COVRIX with the United States Patent and Trademark Office. The USPTO has given the T-COVRIX trademark a serial number of 99515352. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, November 25, 2025. This trademark is owned by ImmunityBio, Inc.. The T-COVRIX trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of infectious diseases; Medicinal preparations for the treatment and prevention of cancer and infectious diseases, including coronavirus, for administration as a vaccine; Pharmaceutical preparations for the prevention of infectious diseases, including coronavirus, for administration as a vaccine; Pharmaceutical preparations for the prevention of cancer, including coronavirus, for administration as a vaccine; Pharmaceutical preparations for the treatment of cancer, including coronavirus, for administration as a vaccine; Biological preparations for the prevention and treatment of cancer and infectious diseases, including coronavirus, for administration as a vaccine